Seed Co., Ltd. AI Stock Analysis
Want to see JP:7743 full AI Analyst Report?
Seed Co., Ltd. (7743) AI Stock Analysis
Seed Co., Ltd.
(TSE/TYO:7743)
The overall score is constrained by significant financial weaknesses, including high leverage and negative free cash flow, which pose substantial risk. Strong technical momentum and a moderate valuation provide some support, but the poor financial health is the most significant factor weighing on the score.
Seed Co., Ltd. (7743) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 23.79B
- Dividend Yield
- 1.91%
- Average Volume (3M)
- 260.64K
- Price to Earnings (P/E)
- 21.8
- Beta (1Y)
- 0.51
- Revenue Growth
- 4.13%
- EPS Growth
- -39.39%
- Country
- Japan
- Employees
- 1,048
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Instruments & Supplies
Seed Co., Ltd. Business Overview & Revenue Model
Company Description
SEED Co.,Ltd. is an international manufacturer and supplier specializing in a broad spectrum of ophthalmic products. The company's extensive range includes various contact lenses, lens care solutions, fashionable spectacle frames, and other vision en...
How the Company Makes Money
Seed Co., Ltd. makes money mainly by selling contact lenses and related eye-care products. Revenue is generated from (1) sales of contact lenses (e.g., disposable and other lens types) and (2) sales of ancillary products associated with contact lens...
Seed Co., Ltd. Financial Statement Overview
Summary
Financial performance is weak. While revenue growth and gross margins are stable, net margins have narrowed and the company posted a recent loss. The balance sheet is highly leveraged with debt-to-equity exceeding 2.0, and cash flow is strained with negative free cash flow for three consecutive periods and a very low operating cash flow coverage ratio of 0.13.
Income Statement
45NeutralBalance Sheet
30NegativeCash Flow
25Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.24B | 33.94B | 33.23B | 32.40B | 30.59B | 28.84B |
| Gross Profit | 15.53B | 15.22B | 14.63B | 14.18B | 11.62B | 12.01B |
| EBITDA | 5.36B | 4.76B | 5.05B | 5.12B | 2.83B | 4.45B |
| Net Income | 1.09B | 1.14B | 1.09B | 1.96B | -316.09M | 1.15B |
Balance Sheet | ||||||
| Total Assets | 66.13B | 62.50B | 51.76B | 49.57B | 40.01B | 41.79B |
| Cash, Cash Equivalents and Short-Term Investments | 5.85B | 4.21B | 7.12B | 9.89B | 4.94B | 3.88B |
| Total Debt | 39.57B | 28.47B | 26.26B | 24.18B | 20.89B | 22.04B |
| Total Liabilities | 47.05B | 42.90B | 33.38B | 31.92B | 27.87B | 29.25B |
| Stockholders Equity | 19.08B | 19.27B | 18.06B | 17.36B | 11.86B | 12.26B |
Cash Flow | ||||||
| Free Cash Flow | -6.78B | -438.07M | -1.70B | 2.19B | 2.79B | 2.15B |
| Operating Cash Flow | 2.95B | 2.69B | 2.98B | 6.02B | 3.35B | 3.27B |
| Investing Cash Flow | -10.11B | -3.84B | -4.57B | -3.76B | -440.73M | -881.61M |
| Financing Cash Flow | 6.74B | -1.91B | -1.13B | 2.64B | -1.82B | -2.42B |
Seed Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7743, the sentiment is Positive. The current price of 786.00 is above the 20-day moving average (MA) of 785.75, above the 50-day MA of 785.20, and above the 200-day MA of 598.99, indicating a bullish trend. The MACD of 4.85 indicates Positive momentum. The RSI at 72.47 is Negative, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7743.
Seed Co., Ltd. Peers Comparison
Overall Rating
JP:773079Outperform
JP:304674Outperform
JP:336074Outperform
JP:588969Neutral
JP:778055Neutral- JP:774354Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:7730 | 79Outperform | JPY 146.69B | 20.55 | ― | 2.72% | 10.18% | 55.86% |
| JP:3046 | 74Outperform | JPY 160.58B | 20.42 | 22.48% | 1.52% | 14.41% | -6.42% |
| JP:3360 | 74Outperform | JPY 223.58B | 17.09 | 9.49% | 2.29% | 6.47% | -3.79% |
| JP:5889 | 69Neutral | JPY 54.32B | 12.50 | ― | 3.84% | 15.36% | 5.16% |
| JP:7780 | 55Neutral | JPY 146.85B | 19.91 | 7.70% | 1.46% | 5.05% | 50.43% |
| JP:7743 | 54Neutral | JPY 23.79B | 21.83 | ― | 1.91% | 4.13% | -39.39% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:7743 | Seed Co., Ltd. | 786.00 | 230.66 | 41.53% | |
| JP:3046 | JINS HOLDINGS | 6820.00 | 488.38 | 7.71% | |
| JP:7780 | Menicon Co | 1918.00 | 590.20 | 44.45% | |
| JP:3360 | Ship Healthcare Holdings | 2622.00 | 123.02 | 4.92% | |
| JP:5889 | Japan Eyewear Holdings Co.,Ltd. | 2216.00 | 269.04 | 13.82% | |
| JP:7730 | Mani, Inc. | 1510.00 | 76.68 | 5.35% |
Seed Co., Ltd. Corporate Events
Seed Co., Ltd. Delivers Modest Q1 Sales Growth Amid Profit Decline and Affirms Full-Year Outlook
Seed Co., Ltd. reported consolidated net sales of ¥8,848 million for the three months ended June 30, 2026, a 3.5% year-on-year increase, while operating profit dipped 2.0% to ¥618 million and ordinary profit fell 14.9%. Profit attributable to owners...
Seed Co., Ltd. Scales Back Phase II Investment at Kounosu Contact Lens Plant
Seed Co., Ltd. has revised its Phase II investment plan for Building No. 4 at the Kounosu Laboratory as it continues to upgrade facilities to meet rising global demand for contact lenses. The company is pursuing production lines that reduce labor nee...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 29, 2026